Roqué M, Sitges M, Sala J, Delgado V, Morales M, Marrugat J, Vila J, Subirana I, Tàssies D, Reverter JC, Castro M, Duran M,

[Effects of raloxifene on endothelial function and hemostasis in women with ischemic heart disease].

Rev Esp Cardiol 2011 Jul; 64 (7): 572-8, PMID: 21601973

Modulation of vascular tone is one of the most relevant estrogen effects. A beneficial effect on endothelial function in postmenopausal women has also been proposed for the selective estrogen receptor modulator raloxifene. However, its effects in women with established cardiovascular disease have not been fully elucidated. In addition, recent trials have generated controversy regarding thromboembolic risk with raloxifene use. The aim of the study was to assess the effect of raloxifene on: a) endothelial function and b) coagulation and fibrinolysis pathways.

Descarregar publicació (PDF 186.63K)